Actuate Therapeutics enters underwriting agreement
Actuate Therapeutics signed an underwriting agreement with Newbridge Securities Corporation for a public offering of 30,985,900 shares and 15,492,950 warrants of common stock, priced at $0.6603 for two shares and one warrant.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed